Drug Shortage Report for TELMISARTAN HCTZ
Report ID | 13155 |
Drug Identification Number | 02390302 |
Brand name | TELMISARTAN HCTZ |
Common or Proper name | TELMISARTAN HCTZ |
Company Name | SIVEM PHARMACEUTICALS ULC |
Market Status | MARKETED |
Active Ingredient(s) | HYDROCHLOROTHIAZIDE TELMISARTAN |
Strength(s) | 12.5MG 80.0MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 30 |
ATC code | C09DA |
ATC description | ANGIOTENSIN II ANTAGONISTS, COMBINATIONS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2017-06-16 |
Estimated end date | 2017-07-17 |
Actual end date | 2017-08-06 |
Shortage status | Resolved |
Updated date | 2017-11-03 |
Company comments | Alternate Sivem pack size available (100s) |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 4705 DOBRIN STREET SAINT-LAURENT, QUEBEC CANADA H4R 2P7 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2017-06-16 | English | Compare |
v2 | 2017-06-16 | French | Compare |
v3 | 2017-06-17 | English | Compare |
v4 | 2017-11-03 | English | Compare |
v5 | 2017-11-03 | French | Compare |
Showing 1 to 5 of 5